BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/9/2026 7:20:40 AM | Browse: 2 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
ELF3 emerges as a novel prognostic indicator implicated in gastric cancer progression and correlated with unfavorable clinical outcomes
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zong-Sheng Sun, Chang-Lei Li, Han-Hui Jing, Zheng-Zhao Wang and Long-Bo Zheng |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Long-Bo Zheng, MD, /, The Affiliated Hospital of Qingdao University, No. 1677 Wutai Street, Huangdao District, Qingdao 266000, Shandong Province, China. zhenglongbo2021@qdu.edu.cn |
| Key Words |
E74-like ETS transcription factor 3; Stomach adenocarcinoma; Tumor; Prognosis; Immune infiltration; Biomarker |
| Core Tip |
E74-like ETS transcription factor 3 (ELF3) is an epithelial transcription factor whose role in stomach adenocarcinoma (STAD) has been unclear. Integrating multi-database analyses with a 100-patient clinical cohort, we show that ELF3 is upregulated in STAD, independently predicts survival, and associates with immune-cell and chemokine infiltration. High ELF3 expression co-occurs with an immunosuppressive tumor microenvironment, suggesting a mechanism for disease progression. These findings position ELF3 as a practical prognostic biomarker and a rational therapeutic target to modulate antitumor immunity in STAD. |
| Citation |
Sun ZS, Li CL, Jing HH, Wang ZZ, Zheng LB. ELF3 emerges as a novel prognostic indicator implicated in gastric cancer progression and correlated with unfavorable clinical outcomes. World J Gastrointest Oncol 2026; In press |
 |
Received |
|
2025-11-06 07:40 |
 |
Peer-Review Started |
|
2025-11-06 08:18 |
 |
First Decision by Editorial Office Director |
|
2025-12-04 09:25 |
 |
Return for Revision |
|
2025-12-05 06:19 |
 |
Revised |
|
2025-12-18 20:37 |
 |
Publication Fee Transferred |
|
2025-12-25 14:50 |
 |
Second Decision by Editor |
|
2026-02-09 02:47 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-02-09 07:20 |
 |
Articles in Press |
|
2026-02-09 07:20 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345